# Schedules of Controlled Substances: Placement of Methoxetamine (MXE) in Schedule I
> **Rule** · Final rule. · Published 2022-06-06 · 87 FR 34166
## Document
- **Document number:** 2022-11933
- **Category:** scheduling
- **Type:** Rule
- **Action:** Final rule.
- **Citation:** 87 FR 34166
- **Publication date:** 2022-06-06
## Abstract

With the issuance of this final rule, the Drug Enforcement Administration places 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1- one (methoxetamine, MXE), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, in schedule I of the Controlled Substances Act to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle, methoxetamine.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2022/06/06/2022-11933/schedules-of-controlled-substances-placement-of-methoxetamine-mxe-in-schedule-i)
---
*AI Analytics · CC0 1.0*